Using historical relapse rates for the design of an innovative Phase 3 study with ofatumumab and siponimod in paediatric multiple sclerosis
MULTIPLE SCLEROSIS JOURNAL(2021)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
MULTIPLE SCLEROSIS JOURNAL(2021)